Furthermore, the exploration of ANKHD1 inhibitor treatment could provide novel therapy strategies for pancreatic cancer, especially in combination with MDM2 inhibitor treatment, which should be verified by further research. This evidence concerns the gene ANKHD1 and pancreatic neoplasm.